4//SEC Filing
Reich Samuel J 4
Accession 0000950170-23-066901
CIK 0001833214other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 8:00 AM ET
Size
5.6 KB
Accession
0000950170-23-066901
Insider Transaction Report
Form 4
Reich Samuel J
DirectorCEO & EXECUTIVE CHAIRMAN
Transactions
- Purchase
Common Stock
2023-11-29$0.89/sh+11,000$9,842→ 219,001 total
Holdings
- 547,698(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Represents 11,000 shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), acquired by the reporting person in an open market transaction.
- [F2]Includes 1,000 shares of Common Stock held jointly by the reporting person and the reporting person's spouse.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001394645
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 8:00 AM ET
- Size
- 5.6 KB